Resultado da Busca
11 de jul. de 2023 · WHO fact sheet on colorectal cancer, including risk factors, symptoms, treatments and prevention.
DelveInsight's " Metastatic Colorectal Cancer (mCRC)- Market Insights, Epidemiology, and Market Forecast-2032 " report delivers an in-depth understanding of the mCRC, historical and forecasted epidemiology as well as the mCRC market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
25 de out. de 2022 · Colorectal cancer (CRC) is the third most common cancer worldwide, with 1.1 million new cases per year, and is the second leading cause of cancer death.1 CRC occurs more frequently in middle- to high-income countries with an eightfold variation in incidence across the world. This rise may be associated with known risk factors, including alcohol intake, tobacco use, obesity, sedentariness and ...
30 de set. de 2022 · Colorectal cancer is a multifactorial disease. It is the third most frequently diagnosed cancer, and the second most common cause of cancer-related deaths worldwide. The etiology of colorectal cancer remains unclear. Although early diagnosis can significantly improve the prognosis, colorectal cancer patients often have no typical clinical manifestations, or display only non-specific signs in ...
In this article, the incidence, mortality, and survival rates for colorectal cancer are reviewed, with attention paid to regional variations and changes over time. A concise overview of known risk factors associated with colorectal cancer is provided, ...
This narrative review summarizes treatment options for patients with unresectable metastatic colorectal cancer, focusing on the importance of genomic profiling to identify KRAS/NRAS/BRAF variants to guide immunotherapy.
Metastatic Colorectal Cancer market trends. Metastatic Colorectal Cancer Market Size was ~USD 13000 Million in 2021, growing at a CAGR of XX% During the Forecast Period from 2023 to 2032.
